Dr. Ramy Saleh joins Dr. Neeraj Agarwal to highlight Actinium-225-PSMA-62, a novel radioligand therapy showing promising efficacy with fewer side effects, offering hope beyond Lutetium-177.
ASCO-GU 2025: Video Interview with Neeraj Agarwal
Dr. Ramy Saleh joins Dr. Neeraj Agarwal to highlight Actinium-225-PSMA-62, a novel radioligand therapy showing promising efficacy with fewer side effects, offering hope beyond Lutetium-177.